Ph.D., MBA, Executive Chairman, Novigenix
Dr. Brian Hashemi is the Executive Chairman of Novigenix. Brian holds a Ph.D. in Applied Physics from Cornell University and an MBA in Entrepreneurship from The Wharton School. For 13 years he was responsible for the development of advanced technologies in the biomedical division of NASA, and he has been an Assistant Professor at Baylor College of Medicine where he began his affiliation in the National Space Biomedical Research Institute.
Clinical Dx Showcase: Novigenix
Novigenix is a leader in the field of ImmunoTranscriptomics™ and application of Machine Learning and Artificial Intelligence on circulating immune cells for early cancer detection and disease monitoring. With its first generation product launched in routine medical practice in Switzerland for early detection of Colorectal Cancer, Novigenix is focused on development of next generation products leveraging full human transcriptome analysis of circulating white blood cells.
Innovation In ImmunoTranscriptomics™ For Early Cancer Detection
Application of Machine Learning on circulating immune cell transcriptome provides deep insights into the immune reaction to onset and development of disease. This talk will review the development of blood tests for early detection of Colorectal Cancer in routine medical practice.